Fig. 2From: Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han populationOverall survival of BCLM patients according to breast cancer subtype. BCLM, breast cancer lung metastases, HR, hormone receptor, HER2, human epidermal growth factor receptor 2, TNBC, triple-negativeBack to article page